Skip to main content
Hit enter to search or ESC to close
Close Search
USAUSA
Menu
  • USA
    • UK
    • EU
    • Rest of the World
  • Menu
AI TechnologyEye Health

An easier way to detect diabetes through technology

By Toku EyesMay 3, 2022May 10th, 2022No Comments

Detecting diabetes is about to get a whole lot easier.

A Kiwi company has created a revolutionary technology called THEIA, which uses AI to examine blood vessels in the eye to detect disease.

To explain the technology Jesse is joined by THEIA founder and CEO Associate Professor Ehsan Vaghefi.

https://tokueyes.com/usa/wp-content/uploads/sites/8/2022/05/aft-20220503-1340-an_easier_way_to_detect_diabetes_through_technology-128.mp3

From Afternoons with Jesse Mulligan
Article originally on www.rnz.co.nz

Recent Posts

  • The eye exam detecting chronic health conditions
  • Toku Appoints Former Google Head of Cardiovascular Health as Chief Health Officer
  • Toku obtains CE and UKCA marks for AI cardiovascular risk assessments through the eye
  • Toku joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
  • Toku Eyes poised for US breakthrough after big industry names back $13m raise

Categories

  • AI Technology
  • Business News
  • Clinical Trials
  • Diabetic Screening
  • Eye Health
  • Previous PostNew Zealand tech company develops tool to detect diseases like diabetes

  • Next PostAI tool detects early signs of eye disease

Toku AI

Toku develops tools using AI and retinal photography to enable accessible healthcare for early and accurate diagnosis of health conditions.

Our AI Platforms

BioAge
CLAiR

Links

Our Research
Our Team
News & Media
Contact Us
Privacy Policy


Toku is a Member of the American Heart Association’s Innovators’ Network

If you’ve discovered a potential vulnerability, please contact our cybersecurity team at security@tokueyes.com
© Toku Eyes 2025 | All rights reserved | website by publiceye creative

Share
Share Share Share Pin
Close Menu
  • USA
    • UK
    • EU
    • Rest of the World
  • Our AI Platforms
    • BioAge
    • CLAiR
  • Our Team
  • Our Research
  • News & Media
  • For Optometrists
  • Contact Us
  • Accessibility
    • Normal
    • Large
    • X-Large